Background A three-dose, oral rotavirus vaccine (Rotavac) was introduced in the universal
immunization program in India in 2016. A prelicensure trial involving 6799 infants was not …

Objective To report background intussusception epidemiology in children under-two years in
Coimbatore district of Tamil Nadu state, India, prior to rotavirus vaccine (RVV) introduction …

Background An association between rotavirus vaccination and intussusception has been
documented in post-licensure studies in some countries. We evaluated the risk of …

Objective Intussusception has been linked with rotavirus vaccine (RVV) as a rare adverse
reaction. In view of limited background data on intussusception in India and in preparation …

Rotavirus vaccines carry a small risk of intussusception mainly 1–7 days after vaccination in
the United States of America, Europe, Australia, and Latin America where the background …

Background India introduced rotavirus vaccines (RVV, monovalent, Rotavac™ and
pentavalent, Rotasiil™) in April 2016 with 6, 10 and 14 weeks schedule and expanded …

Objectives The study aimed to document the association between intussusception in Indian
children and meteorological parameters and examine regional variations. Design A …

Objective To study the epidemiology of intussusception in children< 2 y of age,
postintroduction of Rotavac®(an indigenous oral rotavirus vaccine). Methods A multicenter …

Objective To describe epidemiology of intussusception post-introduction of the rotavirus
vaccine. Methods Hospital-based active surveillance system was set up in three tertiary care …

INTRODUCTION: Intussusception is one of the most common causes of intestinal
obstruction in infants and small children. Intussusception is basically a childhood disease …